Synlett 2011(3): 335-340  
DOI: 10.1055/s-0030-1259320
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Chiral Amine-Triggered Triple Cascade Reactions: A New Approach to Functionalized Decahydroquinolines

Ankita Rai, Atul K. Singh, Santosh Singh, Lal Dhar S. Yadav*
Green Synthesis Lab, Department of Chemistry, University of Allahabad, Allahabad 211002, India
Fax: +91(532)2460533; e-Mail: ldsyadav@hotmail.com;
Further Information

Publication History

Received 18 November 2010
Publication Date:
13 January 2011 (online)

Abstract

A chiral amine-triggered highly enantio- and diastereoselective synthesis yielding 69-94% of cis-decahydroquinolines is reported. The synthetic protocol involves a [2+2+2]-annulation via (S)-diphenylprolinol trimethylsilyl ether catalyzed Michael addition of cyclohexanone to nitroalkenes followed by aza-Henry-hemiaminalization reaction cascade. The process stereoselectively installs five contiguous chiral centers into the quinoline structure.

    References and Notes

  • 1 Guo H.-C. Ma J.-A. Angew Chem. Int. Ed.  2006,  45:  354 
  • 2 Nicolaou KC. Montagnon T. Snyder SA. Chem. Commun.  2003,  551 
  • 3a Dalko PI. Moisan L. Angew Chem. Int. Ed.  2001,  40:  3726 
  • 3b List B. Synlett  2001,  1675 
  • 3c List B. Tetrahedron  2002,  58:  2481 
  • 3d Dalko PI. Moisan L. Angew Chem. Int. Ed.  2004,  43:  5138 
  • 3e Berkessel A. Gröger H. Asymmetric Organocatalysis   Wiley-VCH; Weinheim: 2005. 
  • 3f Seayad J. List B. Org. Biomol. Chem.  2005,  3:  719 
  • 3g Lelais G. Macmillan WC. Aldrichimica Acta  2006,  39:  79 
  • 4a List B. Chem. Commun.  2006,  819 
  • 4b Yua X. Wang W. Org. Biomol. Chem.  2008,  6:  2037 
  • 4c Melchiorre P. Marigo M. Carlone A. Bartoli G. Angew. Chem. Int. Ed.  2008,  47:  6138 
  • 4d Spande TF. Jain P. Garraffo HM. Pannell LK. Yeh HJC. Daly JW. Fukumoto S. Imamura K. Tokuyama T. Torres JA. Snelling RR. Jones TH. J. Nat. Prod.  1999,  62:  5 
  • 4e Jones TH. Gorman JST. Snelling RR. Delabie JHC. Blum MS. Garraffo HM. Jain P. Daly JW. Spande TF. J. Chem. Ecol.  1999,  25:  1179 
  • 4f Daly JW. Garraffo HM. Jain P. Spande TF. Snelling RR. Jaramillo C. Rand AS. J. Chem. Ecol.  2000,  26:  73 
  • 4g Daly JW. Spande TF. Garraffo HM. J. Nat. Prod.  2005,  68:  1556 
  • 5a Enders D. Hüttl MRM. Grondal C. Raabe G. Nature (London)  2006,  44:  861 
  • 5b Enders D. Jeanty M. Bats JW. Synlett  2009,  3175 
  • 5c Grondal C. Jeanty M. Enders D. Nature Chem.  2010,  2:  167 
  • 5d Enders D. Grondal C. Hüttl MRM. Angew. Chem. Int. Ed.  2007,  46:  1570 
  • 5e Wang Y. Han R.-G. Zhao Y.-L. Yang S. Xu P.-F. Dixon DJ. Angew. Chem. Int. Ed.  2009,  48:  1 
  • 5f Eder U. Saver G. Wiechert R. Angew. Chem., Int. Ed. Engl.  1971,  10:  496 
  • 5g Hajor ZG. Parrish DR. J. Org. Chem.  1974,  39:  1615 
  • 5h Halland N. Aburel PS. Jørgensen KA. Angew. Chem. Int. Ed.  2004,  43:  1272 
  • 5i Hong B.-C. Wu M.-F. Tseng H.-C. Liao J.-H. Org. Lett.  2006,  8:  2271 
  • 6a Chandrasekhar S. Mallikarjun K. Pavankumarreddy G. Rao KV. Jagadeesh B. Chem. Commun.  2009,  4985 
  • 6b Wang Y. Yu D.-F. Liu Y.-Z. Wei H. Luo Y.-C. Dixon DJ. Xu P.-F. Chem. Eur. J.  2010,  16:  3922 
  • 6c Urushima T. Sakamoto D. Ishikawa H. Hayashi Y. Org. Lett.  2010,  12:  4588 
  • 7 Ko S. Yao C.-F. Tetrahedron  2006,  62:  7293 
  • 8a Steffan B. Tetrahedron  1991,  47:  8729 
  • 8b Kubanek J. Williams DE. Dilip de Silva E. Allen T. Andersen RJ. Tetrahedron Lett.  1995,  36:  6189 
  • 8c Davis RA. Carroll AR. Quinn RJ. J. Nat. Prod.  2002,  65:  454 
  • 9a Warnick JE. Jessup PJ. Overman LE. Eldefrawi ME. Nimit Y. Daly JW. Albuquerque EX. Mol. Pharmacol.  1982,  22:  565 
  • 9b Daly JW. Nishizawa Y. Padgett WL. Tokuyama T. McCloskey PJ. Waykole L. Schultz AG. Aronstam RS. Neurochem. Res.  1991,  16:  1207 
  • 10 Daly JW. Tokuyama T. Habermehl G. Karle IL. Witkop B. Liebigs Ann. Chem.  1969,  727:  198 
  • 11 Sainani JB. Shah AC. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.  1994,  33:  526 
  • 12 Tokuyama T. Tsujita T. Shimada A. Garraffo HM. Spande TF. Daly JW. Tetrahedron  1991,  47:  5401 
  • 13 Daly JW. Witkop B. Tokuyama T. Nishikawa T. Karle IL. Helv. Chim. Acta  1977,  60:  1128 
  • 14a Oppolzer W. Fröstl W. Weber HP. Helv. Chim. Acta  1975,  58:  593 
  • 14b Girard N. Hurvois J.-P. Moinet C. Toupet L. Eur. J. Org. Chem.  2005,  2269 
  • 15 Efange SMN. Khare AB. Mach RH. Parsons SM. J. Med. Chem.  1999,  42:  2862 
  • 16 Li M. Zuo Z. Wen L. Wang S. J. Comb. Chem.  2008,  10:  436 
  • 17 Tu SJ. Zhou JF. Deng X. Cai PJ. Wang H. Feng JC. Chin. J. Org. Chem.  2001,  21:  313 
  • 18 Sabitha G. Reddy GSK. Reddy CS. Yadav JS. Tetrahedron Lett.  2003,  44:  4129 
  • 19 Ji SJ. Jiang ZQ. Lu J. Loa TP. Synlett  2004,  831 
  • 20 Zhang XY. Li YZ. Fan XS. Qu GR. Hu XY. Wang JJ. Chin. Chem. Lett.  2006,  17:  150 
  • 21 Maheswara M. Siddaiah V. Damu GLV. Venkata Rao C. ARKIVOC  2006,  (ii):  201 
  • 22 Das B. Ravikanth B. Ramu R. Vittal Rao B. Chem. Pharm. Bull.  2006,  54:  1044 
  • 23 Song G. Wang B. Wu X. Kang Y. Yang L. Synth. Commun.  2005,  35:  2875 
  • 24 Reddy CS. Raghu M. Chin. Chem. Lett.  2008,  19:  775 
  • 25 Adibi H. Samimi HA. Beygzadeh M. Catal. Commun.  2007,  8:  2119 
  • 26 Heravi MM. Bakhtiri K. Javadi NM. Bamoharram FF. Saeedi M. Oskooi HA. J. Mol. Catal. A: Chem.  2007,  264:  50 
  • 27 Donelson JL. Gibbs A. De S K. J. Mol. Catal. A: Chem.  2006,  256:  309 
  • 28 Cherkupally SR. Mekalan R. Chem. Pharm. Bull.  2008,  56:  1002 
  • 29 Sapkal SB. Shelke KF. Shingate BB. Shingare MS. Tetrahedron Lett.  2009,  50:  1754 
  • 30 Kibayashi C. Aoyagi S. Stud. Nat. Prod. Chem.  1997,  9:  3 
  • 31a Ballini R. Rosini G. Synthesis  1988,  833 
  • 31b Rosini G. Ballini R. Petrini M. Marotta E. Righi P. Org. Prep. Proced. Int.  1990,  22:  707 
  • 31c Ballini R. Marziali P. Mozzicafreddo A. J. Org. Chem.  1996,  61:  3209 
  • 31d Ballini R. Bosica G. Tetrahedron Lett.  1996,  37:  8027 
  • 31e Ballini R. Bosica G. J. Org. Chem.  1997,  62:  425 
  • 31f Ballini R. Petrini M. Tetrahedron  2004,  60:  1017 
  • 31g Amantini D. Fringuelli F. Piermatti O. Pizzo F. Vaccaro C. J. Org. Chem.  2003,  68:  9263 
  • 31h Marotta E. Righi P. Rosini G. Tetrahedron Lett.  1998,  39:  1041 
  • 31i Areces P. Gil MV. Higes FJ. Romàn E. Serrano JA. Tetrahedron Lett.  1998,  39:  8557 
  • 32 Pinnick HW. Org. React. (N.Y.)  1990,  38:  655 
  • 33a Yadav LDS. Rai A. Synlett  2009,  1067 
  • 33b Yadav LDS. Rai A. Tetrahedron Lett.  2009,  50:  640 
  • 33c Yadav LDS. Rai A. Tetrahedron Lett.  2008,  49:  5751 
  • 33d Awasthi C. Yadav LDS. Synlett  2010,  1783 
  • 34a Yadav LDS. Rai A. Rai VK. Awasthi C. Tetrahedron  2008,  64:  1420 
  • 34b Yadav LDS. Rai VK. Singh S. Singh P. Tetrahedron Lett.  2010,  51:  1657 
  • 34c Yadav LDS. Singh S. Rai VK. Synlett  2010,  240 
  • 34d Singh S. Rai VK. Singh P. Yadav LDS. Synthesis  2010,  2957 
35

General Procedure for the Synthesis of cis -Decahydro-quinolines 5: To a solution of ketone 1 (0.4 mmol) and the catalyst diphenylprolinol trimethylsilyl ether 4a (20 mol%) in 1,4-dioxane (1 mL) was added nitroalkene 2 (0.4 mmol) under stirring. The reaction mixture was stirred at r.t. for 8 h followed by addition of aldimine 3 (0.4 mmol) along with K2CO3 (0.2 mmol) in 1,4-dioxane (2 mL) and stirring at r.t. until complete consumption of aldimine 3 (11-18 h) as indicated by TLC. The reaction mixture was concentrated under reduced pressure and the residue was directly purified by silica gel column chromatography (EtOAc-hexane as eluent) to afford an analytically pure sample of cis-decahydroquinolines 5 (Table  [²] ).
Characterization Data of Representative Compounds cis -5:
Compound cis- 5a: white solid; yield: 78%; mp 178-179 ˚C. IR (KBr): 3589, 2964, 1554, 1534, 1408, 1348, 1174, 1092, 856, 797, 745, 702, 605 cm. ¹H NMR (400 MHz, DMSO-d 6): δ = 1.10-1.33 (m, 4 H), 1.60-1.76 (m, 5 H), 1.92 (br s, 1 H, exch. D2O), 2.34 (s, 3 H), 3.34 (dd, 1 H, J = 11.7, 11.6 Hz), 5.06 (d, 1 H, J = 11.1 Hz), 5.91 (dd, 1 H, J = 11.7, 11.1 Hz), 7.34 (d, 2 H, J = 8.1 Hz), 7.45-7.75 (m, 10 H), 7.72 (d, 2 H, J = 8.5 Hz). ¹³C NMR (100 MHz, DMSO-d 6): δ = 17.1, 18.7, 23.6, 24.3, 25.1, 30.4, 37.9, 42.7, 75.1, 84.8, 124.8, 126.0, 127.4, 128.1, 129.3, 130.6, 131.7, 134.6, 137.9, 140.1, 141.5, 142.7. EIMS: m/z = 506 [M+]. Anal. Calcd for C28H30N2O5S: C, 66.38; H, 5.97; N, 5.53. Found: C, 66.10; H, 5.61; N, 5.83. [α]D ²0 +22 (c = 0.60, THF). The enantiomeric excess was determined to be 97% by HPLC on a chiral Eurocel column (250 × 4.6 mm, 5 µm): λ = 225 nm; i-PrOH-hexane (10:90), flow rate: 1 mL/min; t R = 5.8 min (minor), t R = 6.8 min (major).
Compound cis- 5e: white solid; yield: 90%; mp 189-190 ˚C. IR (KBr): 3598, 2952, 1557, 1532, 1402, 1345, 1161, 1090, 854, 799, 741, 710, 606 cm. ¹H NMR (400 MHz, DMSO-d 6): δ = 1.06-1.30 (m, 4 H), 1.61-1.79 (m, 5 H), 1.94 (br s, 1 H, exch. D2O), 2.36 (s, 3 H), 3.35 (dd, 1 H, J = 11.8, 11.6 Hz), 5.05 (d, 1 H, J = 11.2 Hz), 5.93 (dd, 1 H, J = 11.8, 11.2 Hz), 7.30 (d, 2 H, J = 8.1 Hz), 7.65-7.70 (m, 2 H), 7.66-7.71 (m, 5 H), 7.72 (d, 2 H, J = 8.3 Hz), 8.10-8.17 (m, 2 H). ¹³C NMR (100 MHz, DMSO-d 6): δ = 18.9, 20.1, 21.8, 22.7, 25.2, 27.6, 34.9, 39.3, 75.4, 84.5, 125.1, 126.9, 127.8, 128.6, 129.5, 131.1, 132.9, 134.4, 137.0, 138.3, 140.4, 141.6. EIMS: m/z = 540 [M+]. Anal. Calcd for C28H29ClN2O5S: C, 62.16; H, 5.40; N, 5.18. Found: C, 62.52; H, 5.58; N, 4.86. [α]D ²0 +19 (c = 0.80, THF). The enantiomeric excess was determined to be 91% by HPLC on a chiral Eurocel column (250 × 4.6 mm, 5 µm): λ = 225 nm; i-PrOH-hexane (10:90), flow rate: 1 mL/min; t R = 5.9 min (minor), t R = 7.1 min (major).
Compound cis- 5m: white solid; yield: 71%; mp 187-188 ˚C. IR (KBr): 3592, 2815, 2910, 1559, 1531, 1410, 1340, 1169, 1095, 852, 796, 741, 708, 601 cm. ¹H NMR (400 MHz, DMSO-d 6): δ = 1.09-1.34 (m, 4 H), 1.59-1.76 (m, 5 H), 1.91 (br s, 1 H, exchangeable with D2O), 2.33 (s, 3 H), 3.34 (dd, 1 H, J = 11.6, 11.4 Hz), 3.85 (s, 3 H), 5.09 (d, 1 H, J = 11.2 Hz), 5.95 (dd, 1 H, J = 11.6, 11.2 Hz), 7.31 (d, 2 H, J = 8.0 Hz), 7.61-7.69 (m, 5 H), 7.66-7.68 (m, 2 H), 7.74 (d, 2 H,
J = 8.2 Hz), 8.01-8.03 (m, 2 H). ¹³C NMR (100 MHz, DMSO-d 6): δ = 17.6, 18.8, 21.5, 24.3, 25.6, 28.9, 37.5, 42.1, 49.5, 75.4, 84.2, 114.8, 126.7, 127.9, 128.8, 130.0, 131.7, 132.5, 134.7, 136.7, 138.1, 141.6, 156.6. EIMS: m/z = 536 [M+]. Anal. Calcd for C29H32N2O6S: C, 64.91; H, 6.01; N, 5.22. Found: C, 65.11; H, 5.77; N, 4.93. [α]D ²0 +25 (c = 0.90, THF). The enantiomeric excess was determined to be 94% by HPLC on a chiral Eurocel column (250 × 4.6 mm, 5 µm): λ = 225 nm; i-PrOH-hexane (10:90), flow rate: 1 mL/min; t R = 6.7 min (minor), t R = 7.8 min (major).